Amino Acids of the Human α 1d-Adrenergic Receptor Involved in Antagonist Binding

Computer simulations of the human α 1d-adrenergic receptor (α 1d-AR) based on the crystal structure of rhodopsin have been combined with experimental site-directed mutagenesis to investigate the role of residues in the transmembrane domains in antagonist binding. Our results indicate that the amino...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmacological sciences Vol. 106; no. 1; pp. 114 - 120
Main Authors Yuko Nagaoka, Maruf Ahmed, Murad Hossain, Mohiuddin Ahmed Bhuiyan, Masaji Ishiguro, Takashi Nakamura, Masatomo Watanabe, Takafumi Nagatomo
Format Journal Article
LanguageEnglish
Published Elsevier 01.01.2008
Online AccessGet full text

Cover

Loading…
Abstract Computer simulations of the human α 1d-adrenergic receptor (α 1d-AR) based on the crystal structure of rhodopsin have been combined with experimental site-directed mutagenesis to investigate the role of residues in the transmembrane domains in antagonist binding. Our results indicate that the amino acids Asp176 in the third transmembrane domain (TMD), Glu237 in TMD IV, and Ser258 in TMD V of α 1d-AR were directly involved in prazosin and tamsulosin binding. The Asp176Ala mutant did not exhibit any affinity for [3H]prazosin and neither did it show agonist-stimulated inositol phosphates (IP) formation. On the other hand, the Glu237Ala and Ser258Ala mutant α 1d-AR showed increased binding affinity for [3H]prazosin. Competition binding experiments showed that prazosin affinity had increased to 5-fold and 3-fold in the Glu237Ala and Ser258Ala mutants, respectively, versus wild-type; and tamsulosin affinity only increased in the Ser258Ala mutant (2-fold vs wild-type). It seems that these two residues constrain the receptor by interaction with other residues and this disruption of the interaction increased the receptor’s binding affinity towards antagonists. However, the Glu237Ala and Ser258Ala mutant receptors retained the ability to stimulate the formation of myo-[3H]inositol but had activities lower than that of the wild-type receptor. The present results provide direct evidence that these amino acid residues are responsible for the interactions between α 1d-AR and the radioligand [3H]prazosin as well as tamsulosin. Keywords:: prazosin, tamsulosin, α 1d-adrenergic receptor, site-directed mutagenesis, binding site
AbstractList Computer simulations of the human α 1d-adrenergic receptor (α 1d-AR) based on the crystal structure of rhodopsin have been combined with experimental site-directed mutagenesis to investigate the role of residues in the transmembrane domains in antagonist binding. Our results indicate that the amino acids Asp176 in the third transmembrane domain (TMD), Glu237 in TMD IV, and Ser258 in TMD V of α 1d-AR were directly involved in prazosin and tamsulosin binding. The Asp176Ala mutant did not exhibit any affinity for [3H]prazosin and neither did it show agonist-stimulated inositol phosphates (IP) formation. On the other hand, the Glu237Ala and Ser258Ala mutant α 1d-AR showed increased binding affinity for [3H]prazosin. Competition binding experiments showed that prazosin affinity had increased to 5-fold and 3-fold in the Glu237Ala and Ser258Ala mutants, respectively, versus wild-type; and tamsulosin affinity only increased in the Ser258Ala mutant (2-fold vs wild-type). It seems that these two residues constrain the receptor by interaction with other residues and this disruption of the interaction increased the receptor’s binding affinity towards antagonists. However, the Glu237Ala and Ser258Ala mutant receptors retained the ability to stimulate the formation of myo-[3H]inositol but had activities lower than that of the wild-type receptor. The present results provide direct evidence that these amino acid residues are responsible for the interactions between α 1d-AR and the radioligand [3H]prazosin as well as tamsulosin. Keywords:: prazosin, tamsulosin, α 1d-adrenergic receptor, site-directed mutagenesis, binding site
Author Masaji Ishiguro
Murad Hossain
Takafumi Nagatomo
Maruf Ahmed
Yuko Nagaoka
Takashi Nakamura
Mohiuddin Ahmed Bhuiyan
Masatomo Watanabe
Author_xml – sequence: 1
  fullname: Yuko Nagaoka
  organization: Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 265-1 Higashijima, Akiha-ku, Niigata 956-8603, Japan
– sequence: 2
  fullname: Maruf Ahmed
  organization: Pharmacy Department, University of Rajshahi, Rajshahi-6205, Bangladesh
– sequence: 3
  fullname: Murad Hossain
  organization: Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 265-1 Higashijima, Akiha-ku, Niigata 956-8603, Japan
– sequence: 4
  fullname: Mohiuddin Ahmed Bhuiyan
  organization: Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 265-1 Higashijima, Akiha-ku, Niigata 956-8603, Japan
– sequence: 5
  fullname: Masaji Ishiguro
  organization: Suntory Institute for Bioorganic Research, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan
– sequence: 6
  fullname: Takashi Nakamura
  organization: Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 265-1 Higashijima, Akiha-ku, Niigata 956-8603, Japan
– sequence: 7
  fullname: Masatomo Watanabe
  organization: Department of Public Health, Niigata College of Medical Technology, 5-13-2 Kamishinei-cho, Nishi-ku, Niigata 950-2081, Japan
– sequence: 8
  fullname: Takafumi Nagatomo
  organization: Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 265-1 Higashijima, Akiha-ku, Niigata 956-8603, Japan; Corresponding author. nagatomot@s4.dion.ne.jp
BookMark eNqtzEFKAzEUgOEsKrRV7_AuMDCZpE1cjqK0S8V9eJNkpq_MvJQkFjyWF_FMgngEVz98i38rVpw4rsRGKm0au5dqLbalnNu2s63cb8RrvxAn6D2FAmmEeopw-FiQ4fsLZGj6kCPHPJGHt-jjpaYMR76m-RoDEEPPFafEVCo8Egfi6U7cjDiXeP_XW3F8eX5_OjQh4dldMi2YP11Ccr-Q8uQwV_JzdBrtzqhOBjN4bbWx3aCMNxK16YYxPKj_fP0As4ZZbw
ContentType Journal Article
DBID DOA
DatabaseName Directory of Open Access Journals
DatabaseTitleList
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EndPage 120
ExternalDocumentID oai_doaj_org_article_4a857321d7bc484782b37c71a472bfd9
GroupedDBID ---
.55
0SF
29L
2WC
5GY
5RE
6I.
AACTN
AAEDT
AAEDW
AAFTH
AALRI
AAXUO
ACGFO
ACGFS
ADBBV
ADVLN
AENEX
AFJKZ
AFTJW
AITUG
AKRWK
AL-
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BCNDV
BKOMP
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FDB
GROUPED_DOAJ
GX1
HH5
JMI
JSF
JSH
KQ8
M41
MOJWN
M~E
NCXOZ
OK1
RJT
RNS
ROL
RZJ
TKC
TR2
W2D
X7M
XSB
ZGI
ZXP
ID FETCH-doaj_primary_oai_doaj_org_article_4a857321d7bc484782b37c71a472bfd93
IEDL.DBID DOA
ISSN 1347-8613
IngestDate Tue Oct 22 15:16:01 EDT 2024
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-doaj_primary_oai_doaj_org_article_4a857321d7bc484782b37c71a472bfd93
OpenAccessLink https://doaj.org/article/4a857321d7bc484782b37c71a472bfd9
ParticipantIDs doaj_primary_oai_doaj_org_article_4a857321d7bc484782b37c71a472bfd9
PublicationCentury 2000
PublicationDate 2008-01-01
PublicationDateYYYYMMDD 2008-01-01
PublicationDate_xml – month: 01
  year: 2008
  text: 2008-01-01
  day: 01
PublicationDecade 2000
PublicationTitle Journal of pharmacological sciences
PublicationYear 2008
Publisher Elsevier
Publisher_xml – name: Elsevier
SSID ssj0028016
Score 3.654615
Snippet Computer simulations of the human α 1d-adrenergic receptor (α 1d-AR) based on the crystal structure of rhodopsin have been combined with experimental...
SourceID doaj
SourceType Open Website
StartPage 114
Title Amino Acids of the Human α 1d-Adrenergic Receptor Involved in Antagonist Binding
URI https://doaj.org/article/4a857321d7bc484782b37c71a472bfd9
Volume 106
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV09a8MwEBUlU5fST_oZbiiZYmrZlmWNTmlICi0ppJDNWJYMHqqEJC3kZ_WP9Df1JLkkW4d2NcISJ3j3Trr3RMhtpFmoa14FCXJVLFBYGGAawQ1hgoU1UlJa2hvdp-d09Jo8zths56kv2xPm7YF94O6SMmM8jqjiskoQSrNIxrzitEx4JGvlpXuh-Cmm2lILcdfpimJcQObeLthx5HepY3hIDlrOB7mf64jsaXNMehNvGr3pw3SrgVr1oQeTrZ305oS85G-NmUNeNWoF8xqQsYE7eoevT6AqyK0WWy8RwQA5oF5gEQ1jg6jzoRU0BnJjL56sQS4MGqdhOSXj4cP0fhTYxRYL7zdRWAdo9wHjUrRxKX6LS3xGOmZu9LntXqJaKSE4rXSiMyElTVWKo0TMVFRnF2Tw9_ku_-MnV2Tf92PYI45r0lkv3_UNJv217Lr97VrgZd-917DW
link.rule.ids 315,783,787,2109
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Amino+Acids+of+the+Human+%CE%B1+1d-Adrenergic+Receptor+Involved+in+Antagonist+Binding&rft.jtitle=Journal+of+pharmacological+sciences&rft.au=Yuko+Nagaoka&rft.au=Maruf+Ahmed&rft.au=Murad+Hossain&rft.au=Mohiuddin+Ahmed+Bhuiyan&rft.date=2008-01-01&rft.pub=Elsevier&rft.issn=1347-8613&rft.volume=106&rft.issue=1&rft.spage=114&rft.epage=120&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_4a857321d7bc484782b37c71a472bfd9
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-8613&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-8613&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-8613&client=summon